IGF-1 LR3 is a chemically altered amino acid chain made of 83 amino acids
Site rotation prevents localized reactions, with common areas including the abdomen (2+ inches from navel), outer thighs, and upper arms
Rat studies have also shown positive results
Quick Reference: Injection site reactions: 15-25% (mild, resolve in 2-24 hours) Nausea: 5-10% (transient, first week) Dizziness: 3-7% (occasional, brief) Serious events: Zero documented in 100+ animal studies Typical dose: 250-500 mcg/day SubQ
Each batch is reviewed for peptide integrity, purity levels, and contaminants, with a COA included
In human endothelial cells and a rat hind-limb ischemia model, BPC-157 was associated with VEGFR2 activation and downstream Akt-eNOS signaling